GLP-1 drugs linked to 11-fold higher regurgitation rate under anesthesia

New probe presented astatine the Association of Anaesthetists Annual Meeting successful Liverpool, UK (Sept. 16–18), and published successful the diary Anaesthesia, shows that among patients undergoing surgical procedures nether the attraction of an anesthetist, the complaint of a complication known arsenic regurgitation is 11 times higher among patients taking the caller people of diabetes and obesity medications glucagon-like peptide-1 receptor agonists (GLP-1 RAs) than among patients not taking those drugs—although the implicit hazard of this complication remains small.